Healthcare - Biotechnology - NASDAQ - US
$ 86.88
-3.66 %
$ 6.06 B
Market Cap
-31.14
P/E
Price Target
Average
28.91%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
7.95%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nuvalent, Inc.
Wall Street analysts predict an average 1-year price target for NUVL of $112 , with forecasts ranging from a low of $97 to a high of $135 .
NUVL Lowest Price Target
Wall Street Target
97 USD
11.65%
NUVL Average Price Target
Wall Street Target
112 USD
28.91%
NUVL Highest Price Target
Wall Street Target
135 USD
55.39%
REVENUE FORECAST
Revenue Forecast Chart NUVL
EBIT FORECAST
EBIT Forecast Chart NUVL
NET INCOME FORECAST
Net Income Chart NUVL